Evaluating the effects of CELF1 deficiency inamouse model of RNA toxicity

Human Molecular Genetics

Volumn 23, Issue 2, 2014, Pages 293-302

  Kim, Yun Kyoung ^a   Mandal, Mahua ^a   Yadava, Ramesh S ^a   Paillard, Luc ^b   Mahadevan, Mani S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CUGBP ETR 3 LIKE FACTOR 1; PROTEIN; RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; MUSCLE FUNCTION; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN TARGETING; SKELETAL MUSCLE; SPLICING DEFECT; TOXICITY; TRANSGENE;

ALTERNATIVE SPLICING; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSGENES;

EID: 84903823358     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt419     Document Type: Article

References (42)

1. Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T. et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell, 69, 385.
2. Day, J.W. and Ranum, L.P. (2005) RNA Pathogenesis of the myotonic dystrophies. Neuromuscul. Disord., 15, 5-16.
3. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. and Housman, D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA, 94, 7388-7393.
4. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D. and Singer, R.H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell. Biol., 128, 995-1002.
5. Ladd, A.N., Charlet, N. and Cooper, T.A. (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol., 21, 1285-1296.
6. Miller, J.W., Urbinati, C.R., Teng-Umnuay, P., Stenberg, M.G., Byrne, B.J., Thornton, C.A. and Swanson, M.S. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J., 19, 4439-4448.
7. Fardaei, M., Larkin, K., Brook, J.D. and Hamshere, M.G. (2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res., 29, 2766-2771.
8. Timchenko, L.T., Miller, J.W., Timchenko, N.A., DeVore, D.R., Datar, K.V., Lin, L., Roberts, R., Caskey, C.T. and Swanson, M.S. (1996) Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res., 24, 4407-4414.
9. Mankodi, A., Urbinati, C.R., Yuan, Q.P., Moxley, R.T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M.S. and Thornton, C.A. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet., 10, 2165-2170.
10. Kanadia, R.N., Johnstone, K.A., Mankodi, A., Lungu, C., Thornton, C.A., Esson, D., Timmers, A.M., Hauswirth, W.W. and Swanson, M.S. (2003) A muscleblind knockout model for myotonic dystrophy. Science, 302, 1978-1980.
11. Kanadia, R.N., Shin, J., Yuan, Y., Beattie, S.G., Wheeler, T.M., Thornton, C.A. and Swanson, M.S. (2006) Reversal ofRNAmissplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl Acad. Sci. USA, 103, 11748-11753.
12. Han, J. and Cooper, T.A. (2005) Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res., 33, 2769-2780.
13. Kalsotra, A., Xiao, X., Ward, A.J., Castle, J.C., Johnson, J.M., Burge, C.B. and Cooper, T.A. (2008) A postnatal switch of CELF and MBNL proteins reprogramsalternative splicing in the developing heart. Proc. Natl Acad. Sci. USA, 105, 20333-8.
14. Lee, J.E., Lee, J.Y., Wilusz, J., Tian, B. and Wilusz, C.J. (2010) Systematic analysis of cis-elements in unstablemRNAsdemonstrates thatCUGBP1is a key regulator of mRNA decay in muscle cells. PLoS ONE, 5, e11201.
15. Timchenko, N.A., Wang, G.L. and Timchenko, L.T. (2005) RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. J. Biol. Chem., 280, 20549-20557.
16. Timchenko, L.T., Salisbury, E., Wang, G.L., Nguyen, H., Albrecht, J.H., Hershey, J.W. and Timchenko, N.A. (2006) Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver. J. Biol. Chem., 281, 32806-32819.
17. Kuyumcu-Martinez, N.M., Wang, G.S. and Cooper, T.A. (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell, 28, 68-78.
18. Timchenko, N.A., Patel, R., Iakova, P., Cai, Z.J., Quan, L. and Timchenko, L.T. (2004) Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem., 279, 13129-13139.
19. Ho, T.H., Bundman, D., Armstrong, D.L. and Cooper, T.A. (2005) Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet., 14, 1539-1547.
20. Koshelev, M., Sarma, S., Price, R.E., Wehrens, X.H. and Cooper, T.A. (2010) Heart-specific overexpression ofCUGBP1reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum. Mol. Genet., 19, 1066-1075.
21. Ward, A.J., Rimer, M., Killian, J.M., Dowling, J.J. and Cooper, T.A. (2010) CUGBP1 Overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum. Mol. Genet., 19, 3614-3622.
22. Mahadevan, M.S., Yadava, R.S., Yu, Q., Balijepalli, S., Frenzel-McCardell, C.D., Bourne, T.D. and Phillips, L.H. (2006) Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat. Genet., 38, 1066-1070.
23. Kress, C., Gautier-Courteille, C., Osborne, H.B., Babinet, C. and Paillard, L. (2007) Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol. Cell. Biol., 27, 1146-1157.
24. Philips, A.V., Timchenko, L.T. and Cooper, T.A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
25. Savkur, R.S., Philips, A.V. and Cooper, T.A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 29, 40-47.
26. Charlet, B.N., Savkur, R.S., Singh, G., Philips, A.V., Grice, E.A. and Cooper, T.A. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell, 10, 45-53.
27. Bland, C.S., Wang, E.T., Vu, A., David, M.P., Castle, J.C., Johnson, J.M., Burge, C.B. and Cooper, T.A. (2010) Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res., 38, 7651-7664.
28. Mankodi, A., Takahashi, M.P., Jiang, H., Beck, C.L., Bowers, W.J., Moxley, R.T., Cannon, S.C. and Thornton, C.A. (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell, 10, 35-44.
29. Kino, Y., Washizu, C., Oma,Y., Onishi, H., Nezu, Y., Sasagawa, N., Nukina, N. and Ishiura, S. (2009) MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res, 37, 6477-6490.
30. Ho, T.H., Charlet, B.N., Poulos, M.G., Singh, G., Swanson, M.S. and Cooper, T.A. (2004) Muscleblind proteins regulate alternative splicing. EMBO J., 23, 3103-3112.
31. Du, H., Cline, M.S., Osborne, R.J., Tuttle, D.L., Clark, T.A., Donohue, J.P., Hall, M.P., Shiue, L., Swanson, M.S., Thornton, C.A. et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol., 17, 187-193.
32. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S. and Thornton, C.A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
33. Berger, D.S., Moyer, M., Kliment, G.M., van Lunteren, E. and Ladd, A.N. (2010) Expression of a dominant negative CELF protein in vivo leads to altered muscle organization, fiber size, and subtype. PLoS ONE, 6, e19274.
34. Berger, D.S. and Ladd, A.N. Repression of nuclear CELFactivity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy. PLoS Curr., 4, RRN1305.
35. Yadava, R.S., Frenzel-McCardell, C.D., Yu, Q., Srinivasan, V., Tucker, A.L., Puymirat, J., Thornton, C.A., Prall, O.W., Harvey, R.P. and Mahadevan, M.S. (2008) RNA Toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Nat. Genet., 40, 61-68.
36. Gonnella, P., Alamdari, N., Tizio, S., Aversa, Z., Petkova, V. and Hasselgren, P.O. (2010) C/EBPbeta regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1. J. Cell. Biochem., 112, 1737-1748.
37. Wang, G.S., Kearney, D.L.,De Biasi, M., Taffet, G. and Cooper, T.A. (2007) Elevation of RNA-binding proteinCUGBP1is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J. Clin. Invest., 117, 2802-2811.
38. Timchenko, N.A., Cai, Z.J., Welm, A.L., Reddy, S., Ashizawa, T. and Timchenko, L.T. (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem., 276, 7820-7826.
39. Marchildon, F., Lala, N., Li, G., St-Louis, C., Lamothe, D., Keller, C. and Wiper-Bergeron, N. (2010) CCAAT/Enhancer binding protein beta is expressed in satellite cells and controls myogenesis. Stem Cells, 30, 2619-2630.
40. Thornell, L.E., Lindstom, M., Renault, V., Klein, A., Mouly, V., Ansved, T., Butler-Browne, G. and Furling, D. (2009) Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Neuropathol. Appl. Neurobiol., 35, 603-613.
41. Furling, D., Coiffier, L., Mouly, V., Barbet, J.P., St Guily, J.L., Taneja, K., Gourdon, G., Junien, C. and Butler-Browne, G.S. (2001) Defective satellite cells in congenital myotonic dystrophy. Hum. Mol. Genet., 10, 2079-2087.
42. Wheeler, T.M., Lueck, J.D., Swanson, M.S., Dirksen, R.T. and Thornton, C.A. (2007) Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest., 117, 3952-3957.